CLOV Q1 2026 Earnings EPS Surges Past Estimates Stock Slides Slightly Meta Q1 2026 Earnings EPS Surges Past Estimates Stock Rallies 37 Theriva Biologics TOVX Q1 2026 Earnings Narrowed Loss Beats Expectations as Stock Rises SCNI Q4 2023 Earnings NarrowerThanExpected Loss Fails to Boost Stock as Revenue Remains Absent AGO Q1 2026 Earnings Strong Underwriting Performance Drives Major EPS Surprise Yet Shares Slip MRCY Q1 2026 Earnings Massive EPS Surprise of 284 Drives Stock Higher